1

Natural Medicine Division 2024 Regulatory Agenda

CDOR Natural Medicine Division

The Colorado Department of Revenue (CDOR) submits the following 2024 Regulatory Agenda (Agenda) in fulfillment of the statutory requirements set forth in §2-7-202(6), 2-7-203, and 24-4-103.3(4), C.R.S. Pursuant to state law, annually on November 1 executive-branch agencies must file their Agenda.
Per §2-7- 202(6), C.R.S., the Agenda must contain:

  • (a) A list of new rules or revisions to existing rules that the department expects to propose in the next calendar year;
  • (b) The statutory or other basis for adoption of the proposed rules;
  • (c) The purpose of the proposed rules;
  • (d) The contemplated schedule for adoption of the rules;
  • (e) An identification and listing of persons or parties that may be affected positively or negatively by the rules.

The Agenda is to be filed with Legislative Council Staff for distribution to committee(s) of reference, posted on CDOR’s website, and submitted to the State Library, the Colorado Department of Regulatory Agencies, and the Secretary of State for publication in the Colorado Register.
CDOR must also present its Agenda as part of its “SMART Act” presentation pursuant to §2-7-203(2)(a), C.R.S.
CDOR works with several boards and commissions that promulgate rules; for ease of use for the consumer, those rules are included in CDOR's Agenda.
The Agenda covers Calendar Year 2024 (CY24). 

Natural Medicine Division 2024 Regulatory Agenda

Schedule 

Rule Number and Title
(or Description)

New rule,
revision,
or repeal?

Statutory or
other basis for
adoption of rule

Part of
Mandatory
Rule Review?

Purpose

Stakeholders

Anticipated
Hearing Date

1 CCR 213-1 - Procedures & Administration 
Mar. 1 CCR 213-1, Applicability, Rule
101
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Severability, Rule
102 
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Definitions, Rule
103
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Declaratory Orders,
Rule 104 
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Law Enforcement
Authority Not Impaired by Natural
Medicine Code, Rule 105  
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Duties of all Applicants and Licensees, Rule 201 New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, All Application
Requirements, Rule 202
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Application Denial, Voluntary Withdrawal, and Effect
of License Surrender, Rule 203
New44-50-203  Initial Implementation of SB 23-290 NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Initial Application Requirements, Rule 204 New44-50-203  Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, License Renewal Application Requirements, Rule 205 New44-50-203  Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Owner & Employee License Application Requirements, Rule 206 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Disclosure of
Financial Interests in Regulated Natural Medicine Licenses, Rule 207 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Change of
Ownership Applications, Rule 208
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Change of Location of Regulated Natural Medicine Business, Rule 209 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar. 1 CCR 213-1, Fees, Rule 210New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
1 CCR 213-2 - Regulated Natural Medicine License Operations
Mar.1 CCR 213-2, Business Records Required, Rule 101 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Privileges of
Licensure, Rule 102
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, General
Restrictions, Rule 103
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Security Standards, Rule 201New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Video Surveillance, Rule 202New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Waste Disposal,
Rule 203 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Transport &
Storage, Rule 301 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Inventory Tracking Required, Rule 302New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Minimum Tracking Requirements, Rule 303New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, General Sanitary Requirements, Rule 401New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Prohibited
Chemicals, Rule 402
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Contaminated
Product, Rule 403
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Cultivation
Standards, Rule 404 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Manufacturing
Standards, Rule 405
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Recall of Regulated Natural Medicine Product, Rule 406New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Packaging &
Labeling Requirements: Prior to Transfer to a Testing Facility, Rule 502 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Packaging &
Labeling Requirements: Prior to Transfer to a Healing Center, Rule 503 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Mandatory Testing, Rule 601 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Sampling
Procedures, Rule 602 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Testing Standards, Action Items, and Procedures, Rule 603 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-2, Costs, Rule 604 New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
1 CCR 213-3 - Regulated Natural Medicine License Types 
Mar.1 CCR 213-3, Cultivation License: License Privileges, Rule 101New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Cultivation License: Prohibited Acts, Rule 102New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Cultivation License: Production Management, Rule 103New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Cultivation License: Testing, Rule 104New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Manufacturing
License: License Privileges, Rule 201
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Manufacturing
License: Prohibited Acts, Rule
202
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Manufacturing
License: Testing, Rule 203 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
License Privileges, Rule 301
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Prohibited Acts, Rule 302 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Certification Requirements, Rule 303
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Personnel, Rule 304 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Standard Operating
Procedures, Rule 305
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Analytical Processes, Rule 306
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Proficiency Testing, Rule 307 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Quality Assurance & Quality
Control, Rule 308
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Chain of Custody, Rule 309 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Notification, Rule 310 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Testing License:
Certification Suspension,
Recertification, and Request for Hearing, Rule 311 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Healing Center
License: License Privileges, Rule 401 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Healing Center
License: Prohibited Acts, Rule
402 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Healing Center
License: Facilitator Required,
Rule 403 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Healing Center
License: Licensed Premises
Requirements, Rule 404 
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24
Mar.1 CCR 213-3, Healing Center
License: Regulated Natural
Medicine & Regulated Natural
Medicine Products Sales
Prohibited, Rule 405  
New44-50-203 Initial Implementation of SB 23-290NMD Stakeholder List7/30/24


Back to top
 

Return to CDOR 2024 Agenda and 2023 Report Page